glutathione 400 mg (100 Capsules) CONTINUAL - G Glyteine 400

As early as 1996, a study entitled Reduced intravenous glutathione in the treatment of early Parkinsons disease found that the progression of PD was reduced, and symptoms improved by 42% after only 30 days of treatment

Each batch undergoes independent analytical testing to verify: Compound identity Assay accuracy Purity confirmation Microbial safety Endotoxin levels Heavy metal screening Full batch traceability Research Use Limitation Used solely for in vitro experiments Not permitted for clinical trials involving humans Not permitted for human or veterinary administration Not permitted for investigational human use Independently analysed by Liquilabs s.r.o

This brain disorder is caused by a certain chemotherapy medication

Detection of Exhaled Hydrogen Sulphide Gas in Rats Exposed to Intravenous Sodium Sulphide

Each softgel contains: L-glutathione LipoMicel** Matrix 300 mg